common.study.topics.clinical

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

common.study.values.description

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

The DISCO-RLS Trial is a randomized controlled trial to determine the safety and efficacy of pharmacologic therapy (ropinirole versus placebo and gabapentin versus placebo) for the treatment of Restless Legs Syndrome in patients with End Stage Renal Disease requiring hemodialysis.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Gabapentin

100 mg capsule

Drug - Ropinirole

0.50 mg capsule

Drug - Placebo Gabapentin

Placebo capsule

Drug - Placebo Ropinirole

Placebo capsule

participant.views.study.view.additional

participant.views.study.view.scientific-title

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS Trial): A Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03806530

participant.views.study.view.id

dPNgla